NCT04846738View on ClinicalTrials.gov

Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors in Brain Damaged Patients Admitted to Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

July 14, 2021

Study Completion Date

August 14, 2022

Conditions
Brain Damage
Interventions
DEVICE

Transcranial Doppler

This device measures Mean Systolic Velocity (VMS), Tele-Diastolic Velocity (TDV) and Pulsatility Index (PI),

DEVICE

Pupillometry.

This device measures the photomotor reflex (basic pupil diameter, percentage of variation, latent and slope of the standard photomotor reflex)

Trial Locations (1)

Unknown

CHU Saint-Etienne, Saint-Etienne

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER

NCT04846738 - Transcranial Doppler and Quantitative Pupillometry as Neurological Prognostic Factors in Brain Damaged Patients Admitted to Intensive Care Unit | Biotech Hunter | Biotech Hunter